CLINICAL_TRIALS
trial_result
· 2023-11-27
Clinical Trial Update: A Safety Study of AZD4041 in Healthy Participants [Phase 1]
Summary
A Phase 1 safety study of AZD4041 in healthy participants has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Opioid Use Disorder (OUD) | Phase 1 | Status: COMPLETED | Results posted: 2023-11-27